Literature DB >> 2681324

Treatment of cardiac arrhythmias: when, how and where?

H J Wellens1, P Brugada.   

Abstract

Despite major advances in the understanding of mechanisms, better diagnostic methods and a wide array of new modes of therapy, management of cardiac arrhythmias continues to be a challenge. Because of possible deleterious effects of antiarrhythmic therapy, the decision about when and how to treat should be weighed carefully with emphasis on symptoms and the prognostic significance of the arrhythmia. When possible, the high risk patient should be referred to a center where expertise and diagnostic and therapeutic possibilities allow optimal treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2681324     DOI: 10.1016/0735-1097(89)90375-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

Review 1.  When is drug therapy warranted to prevent sudden cardiac death?

Authors:  B N Singh
Journal:  Drugs       Date:  1991       Impact factor: 9.546

2.  Sotalol in patients with life-threatening ventricular tachyarrhythmias.

Authors:  H J Trappe; H Klein; P Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 3.  Antiarrhythmic drug treatment: need for continuous vigilance.

Authors:  H J Wellens; J L Smeets; M Vos; A P Gorgels
Journal:  Br Heart J       Date:  1992-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.